Full Article Ozempic and other GLP-1 agonists have rapidly gained the status of cultural phenomenon over the past few years
Moreover, a recent clinical study found that blood plasma TMAO levels are positively correlated with the risk of atherosclerotic cardiovascular disorder (ASCVD), and this correlation is dose-dependent ( Accumulating evidence indicates that bile acids play a crucial role in oral-gut microbiota crosstalk and systemic disease network
This review will use the term MASLD, defined as the presence of hepatic steatosis with no other discernible cause, in conjunction with at least one cardiometabolic risk factor (CMRF), such as type 2 diabetes mellitus (T2DM), obesity, hypertension, or dyslipidemia
If your goal is immediate treatment, tirzepatide has the advantage because it is approved, prescribable and backed by more mature evidence
Many patients demand laser surgery for cure
Its active ingredient, semaglutide , is a GLP-1 receptor agonist that significantly aids in long-term weight management by slowing gastric emptying and reducing appetite
